Zhang, Kai
Yang, Chun
Chang, Lijia
Sakamoto, Akemi
Suzuki, Toru
Fujita, Yuko
Qu, Youge
Wang, Siming
Pu, Yaoyu
Tan, Yunfei http://orcid.org/0000-0001-7313-4067
Wang, Xingming
Ishima, Tamaki
Shirayama, Yukihiko
Hatano, Masahiko
Tanaka, Kenji F. http://orcid.org/0000-0003-2511-0057
Hashimoto, Kenji http://orcid.org/0000-0002-8892-0439
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP19dm0107119)
MEXT | Japan Society for the Promotion of Science (19K17054)
Article History
Received: 13 November 2019
Revised: 2 January 2020
Accepted: 13 January 2020
First Online: 27 January 2020
Conflict of interest
: K. H. is an inventor on the filed patent on “The use of (<i>R</i>)-ketamine in the treatment of psychiatric diseases” and "Transforming growth factor β1 in the treatment of depression" . Other authors declare no conflict of interest.